These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24101025)
1. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours. Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025 [TBL] [Abstract][Full Text] [Related]
2. Hepatic surgery for metastases from neuroendocrine tumors. Sarmiento JM; Que FG Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141 [TBL] [Abstract][Full Text] [Related]
3. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience. Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616 [TBL] [Abstract][Full Text] [Related]
4. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients. Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858 [TBL] [Abstract][Full Text] [Related]
5. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679 [TBL] [Abstract][Full Text] [Related]
6. Hepatic neuroendocrine metastases: does intervention alter outcomes? Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381 [TBL] [Abstract][Full Text] [Related]
7. Synchronous resection of primary and liver metastases for neuroendocrine tumors. Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376 [TBL] [Abstract][Full Text] [Related]
8. Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Homayounfar K; Liersch T; Schuetze G; Niessner M; Goralczyk A; Meller J; Langer C; Ghadimi BM; Becker H; Lorf T Int J Colorectal Dis; 2009 Apr; 24(4):409-18. PubMed ID: 19084973 [TBL] [Abstract][Full Text] [Related]
9. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases. Croome KP; Burns JM; G Que F; Nagorney DM Ann Surg Oncol; 2016 Oct; 23(11):3693-3698. PubMed ID: 27188296 [TBL] [Abstract][Full Text] [Related]
10. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach. Nadler A; Cukier M; Milot L; Singh S; Law CH Can J Surg; 2014 Apr; 57(2):E2-8. PubMed ID: 24666455 [TBL] [Abstract][Full Text] [Related]
11. Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Stoeltzing O; Loss M; Huber E; Gross V; Eilles C; Mueller-Brand J; Schlitt HJ Langenbecks Arch Surg; 2010 Feb; 395(2):185-92. PubMed ID: 19506898 [TBL] [Abstract][Full Text] [Related]
12. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies]. Auernhammer CJ; Jauch KW; Hoffmann JN Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340 [TBL] [Abstract][Full Text] [Related]
13. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations. Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286 [TBL] [Abstract][Full Text] [Related]
14. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target. Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
16. Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers - a case-controlled study. Slotta JE; Schuld J; Distler S; Richter S; Schilling MK; Kollmar O Int J Surg; 2014; 12(2):163-8. PubMed ID: 24342081 [TBL] [Abstract][Full Text] [Related]
17. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?]. Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343 [TBL] [Abstract][Full Text] [Related]
18. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases. Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802 [TBL] [Abstract][Full Text] [Related]